$0.9426
-0.02-2.52%
Pre-Market: 9:27 AM EDT
Comments
Loading...
Kronos Bio (KRON) Forecast
NewsEarningsKronos Bio (KRON) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestKronos Bio (NASDAQ:KRON) Stock Quotes, Forecast and News Summary
Kronos Bio Stock (NASDAQ: KRON) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kronos Bio (KRON) stock?
You can purchase shares of Kronos Bio (NASDAQ:KRON) through any online brokerage.
Who are Kronos Bio (KRON) competitors?
Other companies in Kronos Bio’s space includes: Fortress Biotech (NASDAQ:FBIO), Gain Therapeutics (NASDAQ:GANX), FibroGen (NASDAQ:FGEN), Elicio Therapeutics (NASDAQ:ELTX) and Inovio Pharmaceuticals (NASDAQ:INO).
What is the forecast, or price target, for Kronos Bio (KRON) stock?
Kronos Bio has a consensus price target of $7.31.
What is the current price for Kronos Bio (KRON)?
The stock price for Kronos Bio (NASDAQ: KRON) is $0.9426 last updated December 30, 2024 at 9:27 AM EST.
Does Kronos Bio (KRON) pay a dividend?
There are no upcoming dividends for Kronos Bio.
When is Kronos Bio (NASDAQ:KRON) reporting earnings?
Kronos Bio’s Q4 earnings are confirmed for Thursday, March 20, 2025.
Is Kronos Bio (KRON) going to split?
There is no upcoming split for Kronos Bio.
What sector and industry does Kronos Bio (KRON) operate in?
Kronos Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.